Immediate Impact

53 hit
Sub-graph 1 of 24

Citing Papers

Glucagon-like peptide-1 receptor agonists, but not dipeptidyl peptidase-4 inhibitors, reduce alcohol intake
2025 Hit
Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes Association
2025 Hit
2 intermediate papers

Works of Xiangjin Xu being referenced

Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial
2020

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xiangjin Xu 243 160 121 102 89 32 521
Leonardo Gómez Rosso 196 0.8× 115 0.7× 110 0.9× 135 1.3× 57 0.6× 39 563
Machiko Kambayashi 235 1.0× 175 1.1× 92 0.8× 70 0.7× 42 0.5× 23 586
Christos Kalofoutis 182 0.7× 134 0.8× 116 1.0× 79 0.8× 50 0.6× 18 519
Han De-wu 111 0.5× 122 0.8× 168 1.4× 90 0.9× 51 0.6× 28 487
Kazuo Mimura 178 0.7× 125 0.8× 104 0.9× 179 1.8× 25 0.3× 46 554
Tomoe Kinoshita 300 1.2× 223 1.4× 102 0.8× 134 1.3× 31 0.3× 34 591
Mathias M. Mueller 105 0.4× 166 1.0× 71 0.6× 65 0.6× 96 1.1× 16 581
Chengxu Ma 123 0.5× 292 1.8× 68 0.6× 63 0.6× 69 0.8× 25 607
Eleni A. Karavia 160 0.7× 179 1.1× 158 1.3× 156 1.5× 41 0.5× 26 599
Amanda Garza 272 1.1× 244 1.5× 35 0.3× 115 1.1× 41 0.5× 28 583

All Works

Loading papers...

Rankless by CCL
2026